Showing 1,661 - 1,680 results of 21,964 for search '(( significant ((negative decrease) OR (negative breast)) ) OR ( significant decrease decrease ))', query time: 0.47s Refine Results
  1. 1661

    Stress-strain curves of composite. by Hanqiu Wang (13204812)

    Published 2025
    “…The decrease reaches the maximum at a mortar strength of M40. …”
  2. 1662

    Contains all data. by Hanqiu Wang (13204812)

    Published 2025
    “…The decrease reaches the maximum at a mortar strength of M40. …”
  3. 1663
  4. 1664
  5. 1665
  6. 1666
  7. 1667
  8. 1668
  9. 1669
  10. 1670
  11. 1671
  12. 1672

    Table 3_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  13. 1673

    Table 5_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  14. 1674

    Table 7_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  15. 1675

    Table 2_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  16. 1676

    Table 1_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.docx by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  17. 1677

    Image 3_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  18. 1678

    Image 2_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  19. 1679

    Image 4_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.tif by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”
  20. 1680

    Table 4_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

    Published 2025
    “…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”